Regulatory28 Sept 2026, 12:17 pm
Medicamen Biotech: Trading Window Closed for Q2/H1 FY27 Results
AI Summary
Medicamen Biotech Ltd. announced the closure of its trading window for designated persons and their immediate relatives. This closure is effective from October 1, 2026, and will remain in effect until 48 hours after the financial results for the quarter and half year ending September 30, 2026, are announced to the stock exchanges. The company will intimate the date of the Board Meeting for approving these financial results in due course. This action is in accordance with SEBI (Prohibition of Insider Trading) Regulations, 2015, and the company's internal code of conduct.
Key Highlights
- Trading window closed for designated persons.
- Closure starts October 1, 2026.
- Relates to Q2/H1 FY27 financial results.
- Window reopens 48 hours post-results announcement.
- Board meeting date for results to be announced later.
Price Impact
More from MEDICAMEQ